The short version
- What it doesThe actives are petasin and isopetasin, sesquiterpene esters of petasol, and their target is a pathway modern migraine drugs attack from the other end. In trigeminal afferent preparations both reduce evoked calcitonin gene-related peptide release, with pharmacology pointing at inhibition of TRPA1 and TRPV1 channels on those neurons Kleeberg-Hartmann 2021.
- Who it is forPeople with frequent migraine who have discussed prophylaxis with a clinician and want the herbal option, with liver monitoring.
- What to watchPyrrolizidine alkaloids are hepatotoxic and cause veno-occlusive disease of the liver. The whole commercial category exists to remove them, and the removal is a manufacturing claim you are trusting.
How Butterbur works
The active constituents are the sesquiterpene esters petasin and isopetasin. In trigeminal afferent preparations they reduce evoked calcitonin gene-related peptide release, with the pharmacology pointing at inhibition of TRPA1 and TRPV1 channels on those neurons — the same CGRP pathway that the modern monoclonal antibodies and gepants target from the other end. Separate work supports calcium-channel blockade and inhibition of leukotriene synthesis, which is the more likely route for the allergic rhinitis effect of the leaf extracts.
Read the rest of how it works
Sitting alongside all of this in the raw plant are pyrrolizidine alkaloids, which are not incidental impurities but plant constituents; they are bioactivated by hepatic CYP3A4 into pyrrolic esters that alkylate proteins and DNA and produce hepatic sinusoidal obstruction syndrome. Every commercial extract is defined by the removal of those alkaloids, which makes the specification, not the botanical name, the product.
Butterbur: serving, timing and spacing
- Suggested serving
- The migraine literature used 50–75 mg of standardized rhizome extract twice daily. Nothing here should be run without knowing the pyrrolizidine alkaloid specification.
- How often
- Twice daily, as a defined course rather than an indefinite habit
- When
- With food, which reduces the belching that the oil-based softgels otherwise produce. The prophylactic claim is judged over three to four months, so the schedule matters more than the hour
- Spacing that matters for safety
- Do not run it alongside another hepatotoxic drug, meaningful alcohol intake, or anything else loading CYP3A4 - and book the liver enzymes before the first capsule rather than after the third month
General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.
Good to know
This is one of the few supplements where the certificate of analysis is the product. An extract that does not state a pyrrolizidine alkaloid limit is not a safer version of the one that does — it is an unmeasured version. Liver enzymes on a comprehensive metabolic panel (CMP), plus GGT, before starting and during use are not optional here.
Research on Butterbur5 evidence notes: clinical, correlative, theoretical
Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work
Human clinical evidence
Petasin and isopetasin, the active sesquiterpene esters, reduce calcitonin gene-related peptide release from trigeminal afferents in a way consistent with inhibition of TRPA1 and TRPV1 channels — a mechanism in the same pathway the modern anti-CGRP migraine drugs target.
A leaf extract standardized as Ze 339 has been trialed for allergic rhinitis with reported efficacy and safety, which is a separate indication from the rhizome extracts used for migraine.
Case series of hepatobiliary events during migraine therapy with a Petasites hybridus extract are documented in the clinical literature and are the reason the regulatory position changed.
Correlative data
The plant is invasive enough in European waterways that its pyrrolizidine alkaloids have been measured contaminating stream and groundwater — an environmental finding, and a blunt reminder that the toxin is not a manufacturing artifact but the plant itself.
Theoretical / extrapolated benefits
Calcium-channel blockade and leukotriene inhibition are both proposed as additional contributions to the anti-migraine and anti-allergic effects. They are mechanistically plausible and neither is established as the operative one in people.
Sources read for this page
- Borlak J. Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review. Front Neurol 2022 · PMID 35585841
- Kleeberg-Hartmann J. Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels. J Headache Pain 2021 · PMID 33849430
- Anderson N. Hepatobiliary Events in Migraine Therapy with Herbs: The Case of Petadolex, A Petasites Hybridus Extract. J Clin Med 2019 · PMID 31083451
- Kisielius V. The invasive butterbur contaminates stream and seepage water in groundwater wells with toxic pyrrolizidine alkaloids. Sci Rep 2020 · PMID 33188248
- Merk VM. Efficacy and Safety of P. hybridus Leaf Extract Ze 339 for the Treatment of Allergic Rhinitis. Adv Respir Med 2025 · PMID 40558112
- Seremet OC. Toxicity of plant extracts containing pyrrolizidine alkaloids using alternative invertebrate models. Mol Med Rep 2018 · PMID 29620235
Butterbur, the deep readThe mechanism, cell to human, which form, how you would know
What Butterbur actually does
The actives are petasin and isopetasin, sesquiterpene esters of petasol, and their target is a pathway modern migraine drugs attack from the other end. In trigeminal afferent preparations both reduce evoked calcitonin gene-related peptide release, with pharmacology pointing at inhibition of TRPA1 and TRPV1 channels on those neurons Kleeberg-Hartmann 2021. CGRP release from trigeminal terminals is the event the monoclonal antibodies and gepants were designed to prevent; this is a plant doing something in the same pathway, at a different point, with far less precision.
Two further mechanisms are proposed and neither is established. Calcium-channel blockade in vascular smooth muscle is the older explanation, and inhibition of leukotriene synthesis is the more plausible route for the antiallergic effect of the leaf extracts Borlak 2022 Merk 2025. The rhizome extracts used for migraine and the leaf extracts used for rhinitis are different preparations with different constituent profiles, and conflating them is a common error.
Sitting in the same plant is the reason this page exists. Petasites hybridus contains pyrrolizidine alkaloids — senecionine and its relatives — which are not contaminants but constituents. They are not themselves toxic. Hepatic CYP3A4 oxidizes them to dehydro-pyrrolizidine esters, which are electrophilic pyrrolic alkylating agents that bind proteins and DNA in the sinusoidal endothelium. The result is hepatic sinusoidal obstruction syndrome, and the alkaloids are also genotoxic Seremet 2018.
So the pharmacology is bioactivation in the liver of a molecule that is inert until the liver acts on it, which is why the toxicity is dose-cumulative rather than acute, why it targets the liver specifically, and why the commercial answer is removal at manufacture rather than a dose limit at the label.
That the alkaloids belong to the plant and not to the process is demonstrable outside pharmacology entirely. Where butterbur has become invasive along European waterways, its pyrrolizidine alkaloids have been measured contaminating stream and seepage water in groundwater wells Kisielius 2020.
Cell, rodent, human — and where it stops
In neurons. Petasin and isopetasin reduce CGRP release from trigeminal afferents, with the channel pharmacology characterized Kleeberg-Hartmann 2021. That is a mechanistic result in a preparation, at concentrations chosen by the experimenter.
In invertebrate toxicology models, plant extracts containing pyrrolizidine alkaloids show measurable toxicity, which is how comparative screening of PA-containing preparations is done Seremet 2018.
In people, on the allergic indication. The leaf extract Ze 339 has been trialed for allergic rhinitis with reported efficacy and safety Merk 2025. This is a distinct product from the rhizome extracts and its evidence does not transfer to migraine, or its safety record to them.
In people, on the migraine indication, and this is where the chain breaks in an unusual place. The clinical case for Petasites in migraine prophylaxis has been reviewed with its mode of action, pharmacology and safety together Borlak 2022 — and the obstacle to transfer is not the trials. It is that hepatobiliary adverse events during migraine therapy with a Petasites hybridus extract were documented Anderson 2019, and the leading branded product was withdrawn in Germany. The efficacy question and the availability question came apart.
What that leaves a reader with is specific. The trials that supported this were run on one manufacturer's controlled, PA-depleted extract. What is on a shelf today is a different manufacturer's extract, and the evidence transfers only as far as the specification does.
Butterbur — which form, and does it matter
On this page the certificate of analysis is the product, and that is not a figure of speech. Every commercial butterbur extract is defined by what has been taken out. A supercritical carbon dioxide extraction leaves pyrrolizidine alkaloids behind because they are polar and CO2 is not; an ethanolic extract carries them across unless a separate removal step is performed.
An extract that states no pyrrolizidine alkaloid limit is not a gentler product than one that does. It is an unmeasured one. European regulators set daily PA exposure limits in the low micrograms for herbal products; a specification stating parts per billion is a claim somebody has tested, and its absence is not neutral information Kisielius 2020 Seremet 2018.
Rhizome and leaf are different products. The migraine literature is on root and rhizome extracts standardized to petasin and isopetasin, typically 7.5 mg per 50 mg capsule. The antiallergic literature is on the leaf extract Ze 339 Merk 2025. Buying one for the other's indication is buying a different plant part.
Exposure arithmetic. The migraine trials ran 50 to 75 mg of standardized extract twice daily for three to four months, so total exposure across a course is on the order of 9 to 18 g of extract. Pyrrolizidine toxicity is cumulative and idiosyncratic in onset rather than dose-threshold in the ordinary sense Anderson 2019, which is why the relevant number is the total taken over months and not the capsule.
A home tea or tincture of the raw plant is the unpurified form, and the unpurified form is the toxic one. There is no domestic process that removes pyrrolizidine alkaloids.
What would have to be true, and how you would know it was not
The efficacy prediction is a headache diary, and it needs a baseline written down before the first capsule. Migraine days per month, counted for 4 weeks before starting and for 12 weeks after. Prophylaxis in this literature is judged at three months Borlak 2022; a fortnight tells nobody anything, and migraine frequency regresses to the mean so strongly that starting after a bad month guarantees an apparent improvement.
The safety prediction is the one that must not be skipped. ALT and AST before starting, at 6 weeks and at 12 weeks. If the PA-depletion claim on a given product is correct, these should not move. A rise with no other explanation is the prediction that this product failed its specification, and it is the reason the branded extract was withdrawn Anderson 2019. Bilirubin belongs on the same panel.
The prediction that cuts against the herb. If the CGRP mechanism Kleeberg-Hartmann 2021 is the operative one, butterbur should add little on top of a CGRP monoclonal antibody, because the pathway is already blocked downstream. Anyone stacking the two and reporting a large additional benefit is describing something the stated mechanism does not predict.
What nobody has tested yet
Nobody knows whether a fully PA-free butterbur extract retains the clinical effect. That is the central open question and it is answerable: the migraine evidence was generated on extracts made before the strictest depletion standards, and no trial has compared a modern ultra-low-PA preparation against the historical one on migraine days. Until that is done, nobody can say whether current products are safer versions of what worked or merely safer.
The idiosyncratic component of the liver injury is uncharacterized. Hepatobiliary events occurred in people taking a controlled extract Anderson 2019, which means either the depletion failed in specific batches or something other than the alkaloids was responsible. Nobody has separated those two possibilities, and they have opposite implications for whether liver monitoring is sufficient.
And the leaf extract's safety record has not been formally transferred to the rhizome products. Ze 339 has its own trial base Merk 2025; whether its manufacturing controls are representative of the category is unknown, and the category is bought as one thing.
Butterbur — its own safety story, not its category's
This is the one page in this batch where the safety section is the reason the page exists.
Pyrrolizidine alkaloids are hepatotoxic and genotoxic after CYP3A4 bioactivation, and they cause hepatic sinusoidal obstruction syndrome Seremet 2018. They are plant constituents, not contaminants — the same alkaloids have been measured leaching from invasive stands of the plant into groundwater Kisielius 2020. Everything about the commercial product is an attempt to remove them.
Hepatobiliary adverse events during migraine therapy with a Petasites hybridus extract are documented, and the leading branded extract was withdrawn from the German market Anderson 2019. That is not a theoretical risk carried forward from the raw plant; it is what happened with the purified product.
Anyone using it should have liver enzymes checked before and during, and should stop immediately for jaundice, dark urine, right upper quadrant pain, nausea or unexplained fatigue. Do not combine it with other hepatotoxic drugs, with meaningful alcohol intake, or with anything else that loads CYP3A4.
Do not use in pregnancy, in breastfeeding, or in children. Pyrrolizidine alkaloids cross the placenta and appear in breast milk.
Butterbur is an Asteraceae plant. Cross-reactive allergy with ragweed, chrysanthemum, marigold and daisy is real and is the common non-hepatic adverse effect, alongside belching, which is the characteristic complaint with the oil-based softgels.
Never use a home preparation. Tea, tincture and dried herb are the forms with no depletion step at all.
Butterbur safety basics5 points of its own
Its own safety story
- Pyrrolizidine alkaloids are hepatotoxic and cause veno-occlusive disease of the liver. The whole commercial category exists to remove them, and the removal is a manufacturing claim you are trusting.
- Hepatobiliary adverse events led to the withdrawal of the leading branded extract in Germany. Anyone taking this should have liver enzymes checked before and during use, and should stop immediately for jaundice, dark urine, right upper quadrant pain or unexplained fatigue.
- Do not use in pregnancy, breastfeeding or in children, and not alongside other hepatotoxic drugs or meaningful alcohol intake.
- Butterbur is an Asteraceae plant. Cross-reactivity with ragweed, chrysanthemum, marigold and daisy allergy is real.
- Never use a home preparation, tea or tincture of the raw plant. Those are the unpurified form, and the unpurified form is the toxic one.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.
Bloodwork to run5 tests in one order, code CAMERON
The tests that would show it working, and the ones that keep it safe: why each is here and when to recheck.
Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.
Butterbur FAQ5 common questions
- What is Butterbur?
- A migraine-prophylaxis herb whose defining fact is not its efficacy data but its chemistry. The raw plant contains hepatotoxic pyrrolizidine alkaloids, the commercial extracts are defined by having those removed, and the best-known branded product was withdrawn in Germany after hepatobiliary adverse events. Everything about buying this comes down to whether the removal was done and documented.
- What is the suggested dose of Butterbur?
- The migraine literature used 50–75 mg of standardized rhizome extract twice daily. Nothing here should be run without knowing the pyrrolizidine alkaloid specification. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
- Who is Butterbur for?
- People with frequent migraine who have discussed prophylaxis with a clinician and want the herbal option, with liver monitoring.
- Which labs show whether Butterbur is doing anything?
- TSH (Thyroid-Stimulating Hormone), Vitamin B12, Methylmalonic Acid (MMA), Ferritin, Vitamin D (25-Hydroxy). Draw a baseline before you start, then recheck.
- Where can I buy Butterbur?
- Coach Cam sources Butterbur from vetted, top-rated brands on iHerb. Use the buy link on this page.



